Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@bluejaunt100 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::3618749978.png) @bluejaunt100 Gully Foyle

Gully Foyle posts on X about $imab, listing, $nmra, $krtx the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::3618749978/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3618749978/c:line/m:interactions.svg)

- X Week XXX +390%
- X Month XXXXX +57%
- X Months XXXXXX -XX%
- X Year XXXXXX +173%

### Mentions: X [#](/creator/twitter::3618749978/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3618749978/c:line/m:posts_active.svg)


### Followers: XXX [#](/creator/twitter::3618749978/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3618749978/c:line/m:followers.svg)

- X Week XXX +0.41%
- X Month XXX +0.14%
- X Months XXX +16%
- X Year XXX +19%

### CreatorRank: undefined [#](/creator/twitter::3618749978/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3618749978/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::3618749978/influence)
---

**Social category influence**
[cryptocurrencies](/list/cryptocurrencies)  XXXX%

**Social topic influence**
[$imab](/topic/$imab) #6, [listing](/topic/listing) 2.86%, [$nmra](/topic/$nmra) 2.86%, [$krtx](/topic/$krtx) 2.86%, [$cere](/topic/$cere) XXXX%

**Top accounts mentioned or mentioned by**
[@msollender](/creator/undefined) [@biotechobserver](/creator/undefined) [@monacobiotech](/creator/undefined) [@sanctuarybio](/creator/undefined) [@avidresearch](/creator/undefined) [@logarithmicdis](/creator/undefined) [@matthewherper](/creator/undefined) [@drmakaryfda](/creator/undefined) [@biohazard3737](/creator/undefined) [@fakepharmabro](/creator/undefined) [@adamfeuerstein](/creator/undefined) [@adar170](/creator/undefined) [@therealryc](/creator/undefined) [@sportsbios](/creator/undefined) [@plainyogurt21](/creator/undefined) [@jessebrodkin](/creator/undefined) [@katherineeban](/creator/undefined) [@daphnezohar](/creator/undefined) [@brianhc](/creator/undefined) [@megynkelly](/creator/undefined)

**Top assets mentioned**
[Neumora Therapeutics, Inc. Common Stock (NMRA)](/topic/$nmra) [Karuna Therapeutics, Inc. Common Stock (KRTX)](/topic/$krtx) [Cere Network (CERE)](/topic/$cere)
### Top Social Posts [#](/creator/twitter::3618749978/posts)
---
Top posts by engagements in the last XX hours

"@monaco_biotech Politely not politics $IMAB announcement is amusing. A year ago they announced focusing on being US based. Then w/ delisting threatened no real progress new management w/ funding from the PRC they do a XXX announcing they are leveraging the PRC ecosystem and listing in HK"  
[X Link](https://x.com/bluejaunt100/status/1979162772488204529) [@bluejaunt100](/creator/x/bluejaunt100) 2025-10-17T12:29Z XXX followers, XXX engagements


"I wonder if folks at $NMRA look at clinical data. Touting a more specific M4 Currently the one lesson learned from comparing data from $KRTX vs $CERE was that M4 specificity wasnt beneficial. Who knows but perhaps $NMRA given prior performance should omit the hyperbole"  
[X Link](https://x.com/bluejaunt100/status/1942908878447910990) [@bluejaunt100](/creator/x/bluejaunt100) 2025-07-09T11:29Z XXX followers, 2815 engagements


"@monaco_biotech Agree there is real opportunity to be derived from the PRC biotech ecosystem. But it probably is best served by partners who have had success in drug development which would exclude $IMAB. CBC seems like a failed PRC real estate and generic group looking for another $ gig"  
[X Link](https://x.com/bluejaunt100/status/1979233676551471497) [@bluejaunt100](/creator/x/bluejaunt100) 2025-10-17T17:10Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@bluejaunt100 Avatar @bluejaunt100 Gully Foyle

Gully Foyle posts on X about $imab, listing, $nmra, $krtx the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

  • X Week XXX +390%
  • X Month XXXXX +57%
  • X Months XXXXXX -XX%
  • X Year XXXXXX +173%

Mentions: X #

Mentions Line Chart

Followers: XXX #

Followers Line Chart

  • X Week XXX +0.41%
  • X Month XXX +0.14%
  • X Months XXX +16%
  • X Year XXX +19%

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence #


Social category influence cryptocurrencies XXXX%

Social topic influence $imab #6, listing 2.86%, $nmra 2.86%, $krtx 2.86%, $cere XXXX%

Top accounts mentioned or mentioned by @msollender @biotechobserver @monacobiotech @sanctuarybio @avidresearch @logarithmicdis @matthewherper @drmakaryfda @biohazard3737 @fakepharmabro @adamfeuerstein @adar170 @therealryc @sportsbios @plainyogurt21 @jessebrodkin @katherineeban @daphnezohar @brianhc @megynkelly

Top assets mentioned Neumora Therapeutics, Inc. Common Stock (NMRA) Karuna Therapeutics, Inc. Common Stock (KRTX) Cere Network (CERE)

Top Social Posts #


Top posts by engagements in the last XX hours

"@monaco_biotech Politely not politics $IMAB announcement is amusing. A year ago they announced focusing on being US based. Then w/ delisting threatened no real progress new management w/ funding from the PRC they do a XXX announcing they are leveraging the PRC ecosystem and listing in HK"
X Link @bluejaunt100 2025-10-17T12:29Z XXX followers, XXX engagements

"I wonder if folks at $NMRA look at clinical data. Touting a more specific M4 Currently the one lesson learned from comparing data from $KRTX vs $CERE was that M4 specificity wasnt beneficial. Who knows but perhaps $NMRA given prior performance should omit the hyperbole"
X Link @bluejaunt100 2025-07-09T11:29Z XXX followers, 2815 engagements

"@monaco_biotech Agree there is real opportunity to be derived from the PRC biotech ecosystem. But it probably is best served by partners who have had success in drug development which would exclude $IMAB. CBC seems like a failed PRC real estate and generic group looking for another $ gig"
X Link @bluejaunt100 2025-10-17T17:10Z XXX followers, XXX engagements

creator/x::bluejaunt100
/creator/x::bluejaunt100